Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cynata Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
The life sciences investment wave is building. Here’s how to ride it.
Health & Biotech
When is the right time for a biotech to try and woo big pharma?
News
Lunchtime ASX small cap wrap: Who’s pointing the finger today?
Health & Biotech
Health: Cynata has finally scored that Fujifilm deal; shares climb 27pc
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health: Orthocell has done it again as patients regain shoulder function following CelGro surgery
Health & Biotech
Health: Pharmaxis tumbles way into the red as fortunes fluctuate on handballed drug
News
Hot Money Monday: The most in-demand stocks on the ASX right now
Health & Biotech
What is regenerative medicine? Cynata’s CEO explains
News
It’s not just Labor’s franking credit threat that’s already sending investors to America
Health & Biotech
The caps will stay, but here’s how Labor’s R&D reform might fire up Aussie innovation again
A host of ASX small caps just got a boost from positive news out of the lab
News
Tl;dr? Here are your Budget cliff notes on what’s in store for ASX small caps
Health & Biotech
There’s a bit of promise for health small caps in the federal Budget – but there’s also a big ‘if’
Health & Biotech
Cynata Therapeutics now a ‘buying opportunity’ says Shaw and Partners
Health & Biotech
Health: Impression Healthcare to sell medicinal cannabis, conduct trials
News
